Search

everythinglearnresearchcommunity

for

Search:↓

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hair loss linked to higher heart disease risk in both men and women.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

New treatments for male hypogonadism are effective and should be personalized.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

The circadian clock influences the behavior and regeneration of stem cells in the body.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.